gefitinib has been researched along with singlet oxygen in 2 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (singlet oxygen) | Trials (singlet oxygen) | Recent Studies (post-2010) (singlet oxygen) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 3,870 | 4 | 2,322 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, N; Jia, X; Weng, H; Xue, JP; Ye, HN; Yu, Y | 1 |
| Chen, J; Huang, K; Huo, B; Li, D; Xue, J | 1 |
2 other study(ies) available for gefitinib and singlet oxygen
| Article | Year |
|---|---|
Small molecular target-based multifunctional upconversion nanocomposites for targeted and in-depth photodynamic and chemo-anticancer therapy.
Topics: Antineoplastic Agents; Cell Death; Cell Survival; Gefitinib; Hep G2 Cells; Humans; Nanocomposites; Photochemotherapy; Singlet Oxygen; Small Molecule Libraries; Spectrophotometry, Ultraviolet | 2019 |
Enhanced Efficacy of Gefitinib in Drug-Sensitive and Drug-Resistant Cancer Cell Lines after Arming with a Singlet Oxygen Releasing Moiety.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gefitinib; Humans; Molecular Structure; Singlet Oxygen | 2020 |